End-Stage Age-Related Macular Degeneration is the leading cause of blindness. The disease creates a permanent central vision blind spot, making it difficult or impossible to recognize even close family or friends.
Smaller than a pea, the telescope implant uses wide-angle micro-optics to improve vision for patients with end-stage AMD, the most advanced form of macular degeneration.
The tiny telescope is implanted in the place of the eye’s lens to help improve vision in patients with end-stage AMD, the leading cause of blindness.
CentraSight’s implantable telescope technology reduces the impact of the central vision blind spot due to end-stage AMD. The telescope implant projects the objects the patient is looking at onto the healthy area of the light-sensing retina not degenerated by the disease.
CentraSight’s implantable telescope technology helps improve vision in patients with the most advanced form of macular degeneration, end-stage AMD while being virtually unnoticeable in the eye.
The implantable miniature telescope is not for everyone with macular degeneration. The severe risks involved require careful consideration and conversation with the doctor before proceeding. In addition, the US Food and Drug Administration requires that individuals meet specific criteria to qualify for this device.
All IALVS member doctors can advise you on the risks and rewards of the implantable miniature telescope.
If you believe you are a candidate or for more information, call an IALVS doctor for a free telephone interview.